Trials / Completed
CompletedNCT04351295
Efficacy of Faviprevir in COVID-19 Treatment
Clinical Study Evaluating the Efficacy of Faviprevir in COVID-19 Treatment
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Faviprevir in COVID-19 treatment
Detailed description
Clinical Study Evaluating the Efficacy of Faviprevir in COVID-19 treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Favipiravir | Favipiravir |
| DRUG | Chloroquine | chloroquine oral tablets |
Timeline
- Start date
- 2020-04-20
- Primary completion
- 2020-09-28
- Completion
- 2020-09-28
- First posted
- 2020-04-17
- Last updated
- 2021-11-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04351295. Inclusion in this directory is not an endorsement.